Innate Pharma S.A.

EPA:IPH.PA

2.05 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 16.55710.72235.34420.0998.3096.04341.27122.7952.7935.6969.3196.65626.99216.85329.84118.37317.38613.3351.58829.57835.47835.47811.49811.49811.3811.3810.63710.63722.51822.51810.34310.34310.25110.2512.322.321.7431.7432.0682.0684.8374.8373.4893.4893.2823.282
Cost of Revenue 12.28512.28515.72715.72713.35413.35412.47812.47812.89812.89810.60410.6044.65213.55715.7515.755.18321.1318.29218.29218.61718.61716.16116.16117.70917.70915.79215.79214.17814.17810.13710.1378.5768.5766.3776.3777.2247.2244.1124.1122.7442.7442.6062.6061.951.95
Gross Profit 4.272-1.56319.6184.373-5.045-7.31128.79310.317-10.105-7.203-1.285-3.94822.343.29614.0922.62312.203-7.80133.29611.28616.86216.862-4.663-4.663-6.329-6.329-5.155-5.1558.3418.3410.2060.2061.6751.675-4.057-4.057-5.481-5.481-2.044-2.0442.0932.0930.8840.8841.3321.332
Gross Profit Ratio 0.258-0.1460.5550.218-0.607-1.210.6980.453-3.618-1.265-0.138-0.5930.8280.1960.4720.1430.702-0.5850.6450.3820.4750.475-0.406-0.406-0.556-0.556-0.485-0.4850.370.370.020.020.1630.163-1.749-1.749-3.144-3.144-0.988-0.9880.4330.4330.2530.2530.4060.406
Reseach & Development Expenses 23.72212.28528.40915.72725.16313.35423.68212.47825.81112.89820.32110.60421.78713.55725.35415.7533.16421.1330.23618.29218.61718.61716.16116.16117.70917.70915.79215.79214.17814.17810.13710.1378.5768.5766.3776.3775.8915.8915.4455.4454.0644.0643.5023.5022.8642.864
General & Administrative Expenses 4.4854.4854.5014.5015.0715.0715.8835.8836.3026.3026.2646.26415.8898.22613.5546.88315.8368.1178.6884.5182.6822.6822.6822.68212.3684.6483.863.862.8672.8671.671.671.641.641.3641.3642.332.331.7781.7782.0162.0161.621.621.5661.566
Selling & Marketing Expenses 0.0870.0870.0710.0710.0780.0780.1880.1880.1390.1390.0580.0580.1650.1530.3630.3630.1380.1380.130.130.0930.0930.1070.1070.4260.1010.1010.1010.2250.2250000000.0360.0360.0940.0940.0660.0660.0760.0760.0920.092
SG&A 8.5434.5728.5434.5729.5685.14811.3726.075.5066.44113.3856.32216.0538.37813.9167.24515.9738.2548.8174.6486.2836.2832.7882.7884.5474.5473.9613.9613.0923.0921.671.671.641.641.3641.3640.5880.5881.8721.8722.0812.0811.6961.6961.6581.658
Other Expenses 0000000000000000000000000000000000000000000000
Operating Expenses 32.2654.02936.9523.83434.73124.9935.0547.13131.3176.80433.7064.79237.8430.14739.277.87549.1379.48339.0535.098.1858.1853.3953.3956.66.66.4966.4961.1961.1961.7591.7591.491.490.080.080.0890.0892.4332.4332.552.551.9951.9952.232.23
Operating Income -17.156-6.135-5.253-0.2-28.804-12.4594.1754.247-30.901-13.643-26.579-10.27-17.412-5.1-16.148-4.174-41.455-18.2545.7094.72810.02410.024-7.451-7.451-10.876-10.876-9.116-9.1165.2495.249-1.464-1.4640.0350.035-5.421-5.421-5.452-5.452-4.531-4.531-0.307-0.307-1.088-1.088-0.591-0.591
Operating Income Ratio -1.036-0.572-0.149-0.01-3.467-2.0620.1010.186-11.064-2.395-2.852-1.543-0.645-0.303-0.541-0.227-2.384-1.3690.1110.160.2830.283-0.648-0.648-0.956-0.956-0.857-0.8570.2330.233-0.142-0.1420.0030.003-2.337-2.337-3.128-3.128-2.19-2.19-0.063-0.063-0.312-0.312-0.18-0.18
Total Other Income Expenses Net 2.9931.4912.1171.059-39.309-19.715-2.069-1.0591.484-0.361-2.0731.535-43.123-21.726-0.919-0.993-1.891.2550.0371.892-0.941-0.941-0.275-0.275-1.454-1.454-2.564-2.5642.8072.807-0.122-0.1220.6260.6261.4081.4080.1480.1480.0120.0120.0230.023-0.074-0.0740.0020.002
Income Before Tax -14.163-4.644-3.1360.859-68.113-32.1742.1063.188-29.417-14.004-28.652-8.735-60.535-26.825-17.067-5.167-43.345-175.7466.629.0849.084-7.726-7.726-12.329-12.329-11.68-11.688.0568.056-1.586-1.5860.660.66-4.013-4.013-5.304-5.304-4.52-4.52-0.285-0.285-1.162-1.162-0.589-0.589
Income Before Tax Ratio -0.855-0.433-0.0890.043-8.197-5.3250.0510.14-10.532-2.459-3.075-1.312-2.243-1.592-0.572-0.281-2.493-1.2750.1110.2240.2560.256-0.672-0.672-1.083-1.083-1.098-1.0980.3580.358-0.153-0.1530.0640.064-1.73-1.73-3.043-3.043-2.185-2.185-0.059-0.059-0.333-0.333-0.179-0.179
Income Tax Expense -4.8750-4.8540-3.7650-4.270-7.6580-4.9330-6.8850-6.7330-9.3460-7.4940000.1670.1670.1840.184000.1510.1510000000000000000
Net Income -9.288-4.6441.7180.859-64.406-32.1746.3033.188-29.09-14.004-23.719-8.735-53.65-26.825-10.334-5.167-33.999-1713.246.629.0849.084-7.559-7.559-12.513-12.513-11.68-11.687.9067.906-1.586-1.5860.660.66-4.013-4.013-5.304-5.304-4.52-4.52-0.285-0.285-1.162-1.162-0.589-0.589
Net Income Ratio -0.561-0.4330.0490.043-7.751-5.3250.1530.14-10.415-2.459-2.545-1.312-1.988-1.592-0.346-0.281-1.956-1.2750.2570.2240.2560.256-0.657-0.657-1.1-1.1-1.098-1.0980.3510.351-0.153-0.1530.0640.064-1.73-1.73-3.043-3.043-2.185-2.185-0.059-0.059-0.333-0.333-0.179-0.179
EPS -0.11-0.0580.0210.01-0.8-0.410.0790.04-0.37-0.17-0.3-0.11-0.68-0.34-0.13-0.066-0.52-0.240.210.10.150.15-0.13-0.13-0.23-0.23-0.22-0.220.140.14-0.03-0.030.010.01-0.075-0.076-0.1-0.1-0.095-0.096-0.007-0.007-0.031-0.031-0.016-0.016
EPS Diluted -0.11-0.0580.0210.01-0.8-0.40.0770.039-0.37-0.17-0.3-0.11-0.68-0.34-0.13-0.066-0.52-0.240.20.10.150.15-0.13-0.13-0.23-0.23-0.22-0.220.140.14-0.029-0.0290.0120.012-0.075-0.076-0.1-0.1-0.095-0.096-0.007-0.007-0.031-0.031-0.016-0.016
EBITDA -15.708-5.198-1.6081.409-26.422-11.0056.2174.995-28.524-12.162-24.387-9.453-10.848-2.567-9.429-0.815-31.751-13.82912.5358.14112.47312.473-6.232-6.232-9.743-9.743-8.052-8.0526.0996.099-0.682-0.6820.8740.874-4.933-4.933-4.821-4.821-3.99-3.99-0.082-0.082-0.873-0.873-0.386-0.386
EBITDA Ratio -0.949-0.485-0.0450.07-3.18-1.8210.1510.219-10.213-2.135-2.617-1.42-0.402-0.152-0.316-0.044-1.826-1.0370.2430.2750.3520.352-0.542-0.542-0.856-0.856-0.757-0.7570.2710.271-0.066-0.0660.0850.085-2.126-2.126-2.766-2.766-1.929-1.929-0.017-0.017-0.25-0.25-0.117-0.117